SCIEX Appoints New President to Drive Innovation

In a significant leadership shift, SCIEX, a renowned leader in life science analytical technologies, has appointed Chris Hagen as its new President. This strategic appointment is expected to bolster SCIEX’s operational and commercial prowess, catalyzing further innovations in the field of analytical science. 

SCIEX has a rich legacy in life science analytics, noted for its pioneering contributions since the launch of the first successful triple quadrupole mass spectrometer in 1981. Chris Hagen joins SCIEX with over two decades of experience in the healthcare industry, having previously held leadership roles at Beckman Coulter Diagnostics, Hospira, and Abbott. His extensive expertise in driving strategic vision and innovation is set to enhance SCIEX’s market position, as the company continues its mission to provide solutions that enable life science experts to tackle complex quantitation and characterization challenges. Building on years of consistency in influential research outcomes, SCIEX’s appointment of Hagen underscores its commitment to maintaining industry leadership and reliability in cutting-edge analytical technologies.